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Abstract
The innate immune system is paramount in the response to and clearance of influenza A
virus (IAV) infection in non-immune individuals. Known factors include type I and III interfer-
ons and antiviral pathogen recognition receptors, and the cascades of antiviral and pro- and
anti-inflammatory gene expression they induce. MicroRNAs (miRNAs) are increasingly rec-
ognized to participate in post-transcriptional modulation of these responses, but the tempo-
ral dynamics of how these players of the antiviral innate immune response collaborate to
combat infection remain poorly characterized. We quantified the expression of miRNAs and
protein coding genes in the lungs of pigs 1, 3, and 14 days after challenge with swine IAV
(H1N2). Through RT-qPCR we observed a 400-fold relative increase in IFN-λ3 gene expres-
sion on day 1 after challenge, and a strong interferon-mediated antiviral response was
observed on days 1 and 3 accompanied by up-regulation of genes related to the pro-inflam-
matory response and apoptosis. Using small RNA sequencing and qPCR validation we
found 27 miRNAs that were differentially expressed after challenge, with the highest number
of regulated miRNAs observed on day 3. In contrast, the number of protein coding genes
found to be regulated due to IAV infection peaked on day 1. Pulmonary miRNAs may thus
be aimed at fine-tuning the initial rapid inflammatory response after IAV infection. Specifi-
cally, we found five miRNAs (ssc-miR-15a, ssc-miR-18a, ssc-miR-21, ssc-miR-29b, and
hsa-miR-590-3p)–four known porcine miRNAs and one novel porcine miRNA candidate–to
be potential modulators of viral pathogen recognition and apoptosis. A total of 11 miRNAs
remained differentially expressed 14 days after challenge, at which point the infection had
cleared. In conclusion, the results suggested a role for miRNAs both during acute infection
as well as later, with the potential to influence lung homeostasis and susceptibility to second-
ary infections in the lungs of pigs after IAV infection.
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Introduction
Influenza A is an RNA virus of the Orthomyxoviridae family with a single-stranded, negative
sense segmented genome causing highly contagious respiratory infections in many species,
including humans and pigs. Seasonal influenza in humans is a self-limiting disease, and healthy
individuals usually recover within a week. However, in vulnerable individuals, such as the
elderly, the immunocompromised, or individuals with chronic low-grade inflammation, the
course of disease may be more severe, with a higher incidence of secondary infections and fatali-
ties [1]. New variant viruses emerge continuously due to accumulation of mutations in the viral
genome during replication. Due to these continuous antigenic changes, immunity that is
acquired during one influenza season (either by natural infection or vaccination) often provide
insufficient protection against the strains that dominate the following seasons [2]. Control of
the IAV infection is therefore highly dependent on an efficient innate immune response [3].
It has been documented that IAV infection induces a rapid interferon response dominated
by type I interferons (IFN-α, IFN-β) and the more recently described type III interferons
(IFN-λ) [4,5]. Interferons are responsible for the induction of a multitude of genes termed
interferon-stimulated genes (ISGs), including PKR, Mx1, IFITMs, and ISG15. These ISGs
establish an antiviral state within the cell that effectively combats the infection and spreads to
neighboring cells via secreted interferon [5]. This innate antiviral response is initiated by path-
ogen recognition receptors (PRRs) that recognize viral RNA, such as the cytoplasmic Toll-like
receptors (TLRs) 3 and 7 and the RIG-I-like receptors (RLRs) RIG-I and MDA5 [3]. Upon
PRR recognition of IAV, adapter proteins such as MyD88, MAVS, and TRIF initiate signaling
cascades that ultimately lead to the production of cytokines such as IL-1, IL-6, and TNF, as
well as chemokines IL-8, CXCL2, and CXCL10 that recruit monocytes and macrophages to
the infected tissue [6–8].
The pig has proven to be a valid model for human IAV infection as it displays many relevant
characteristics for human IAV infection. The pathogenesis of IAV infection is highly similar in
pigs and humans [9,10], pigs are natural hosts for IAV and carry an IAV receptor distribution
which is similar to humans’ [11–13], they have extensive immunological and physiological simi-
larities to humans [14–16], and pigs present clinical signs upon IAV infection that are compara-
ble to humans’ [9,17]. Many aspects of the porcine local pulmonary tissue response are however
still unresolved. Particularly, there is a lack of knowledge regarding the role of microRNA
(miRNA) involvement in the innate immune response against viral infections. Since their dis-
covery in the early 1990ies, miRNAs have been demonstrated to be associated with a multitude
of cellular and developmental processes [18–20]. miRNAs are a class of short (~22 nt) non-cod-
ing RNA molecules that regulate translation via antisense complementarity to target mRNA
transcripts. miRNA-mRNA interaction will typically lead to destabilization and degradation of
the mRNA target, thereby effectively inhibiting the protein output [21,22].
A vast range of pathologies have been found to induce changes in host miRNA expression,
including many viral infections [23,24]. This has prompted research into the field of therapeu-
tic and biomarker potential for miRNAs in viral infections and many other diseases. In recent
years, several studies describing miRNA expression during IAV infection have emerged.
Among these are studies in both animal [25,26] and in vitro [27–29] models demonstrating
that different IAV strains and subtypes of varying virulence induce distinct miRNA responses
in the host. Given the potential importance of miRNAs in the modulation of inflammatory
responses [30,31], miRNAs are likely to play an important role in the refinement of the innate
immune defense against IAV.
Investigations into miRNA regulation of innate immune processes have provided experi-
mental evidence for a large number of miRNA-target interactions [32]. A number of in silico
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resources for miRNA target prediction are likewise available [33]. Combined, the large num-
ber of miRNAs that are experimentally validated or computationally predicted to target
immune-related transcripts yields a long list of miRNAs for which the function in relation to
IAV infection is important to clarify. One miRNA may potentially bind to and modulate the
translation of many different mRNA targets; in addition, one mRNA may contain binding
sites and thus be a target for many different miRNAs [34,35]. The high complexity of miRNA-
mRNA regulatory networks can make it challenging to generate hypotheses for studies on
miRNA expression and regulation. Small RNA sequencing (RNAseq) offers a hypothesis-free
approach for researchers to investigate miRNA expression, as this method does not require
any sequence specific primers or probes in order to perform miRNA quantification, in con-
trast to more traditional gene expression methodologies such as microarrays or reverse tran-
scription quantitative real-time PCR (RT-qPCR). However, studies that comprehensively
compare and validate miRNA expression results obtained by RNAseq and qPCR are scarce but
greatly needed in order to generate valid and reproducible data in miRNA research.
Materials and methods
Methods and analyses are described here briefly and summarized in Fig 1; fully detailed
descriptions are contained in S1 Appendix.
Animals and challenge
The challenge experiment will be described briefly, as details have been described previously
[8]. All procedures and animal care was carried out in accordance with Good Clinical Practice
(VICH GL9, CVMP/VICH/595/98), the Directive 2001/82/EC on the Community code relat-
ing to veterinary medicinal products, and German Animal Protection Law. The protocol IDT
Fig 1. Overview of experimental procedures. RNA extraction and RT-qPCR procedures (boxed in red) were
performed in-house, whereas small RNA sequencing (boxed in blue) was performed by an external service provider
(Exiqon A/S).
https://doi.org/10.1371/journal.pone.0194765.g001
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A 03/2004 was approved by the Landesverwaltungsamt Sachsen-Anhalt, Germany (Reference
Number: AZ 42502-3-401 IDT). 25 pigs were included in the present study. 20 pigs were
experimentally infected by aerosol exposure (6 l cell culture supernatant containing 104.55
TCID50/ml) to the Danish swine IAV strain A/sw/Denmark/12687/03 (H1N2) [36], and 5
unchallenged animals were used as controls; all animals were confirmed seronegative for IAV
H1N1, H1N2, and H3N2 subtypes. Clinical signs (body temperature and dyspnea) were
recorded during the first 72 h after challenge. Dyspnea was scored as described previously [8]:
0 = breathing unaffected; 1 = increased respiratory frequency and moderate flank movement;
2 = marked pumping breathing and severe flank movement; 3 = labored breathing affecting
the entire body, pronounced flank movement and substantial movements of the snout;
4 = severe breathing reflecting substantial lack of oxygen. Infected animals were euthanized at
1 day (n = 6), 3 days (n = 6), and 14 days (n = 8) after challenge. Control animals (n = 5) were
euthanized on day 14. Lung tissue samples of 500 mg were collected from the left cranial lobe
from regions with no gross lesions, and immediately stabilized in RNAlater (Qiagen) and
stored at -20˚C. IAV content in lungs and nasal swabs was determined by RT-qPCR at several
time points after challenge as previously described [8].
RNA extraction
Total RNA was isolated using M-tubes and a gentleMACS Octo Dissociator (Miltenyi Biotec)
for tissue homogenization and the miRNeasy Mini Kit (Qiagen) for extraction, according to
the manufacturer’s specifications. For each sample, approx. 35 mg lung tissue was homoge-
nized in 1 ml QIAzol Lysis Reagent (Qiagen). The lysate was mixed with 200 μl chloroform
and centrifuged at 4˚C and 12,000xg for 15 min. The rest of the procedure was carried out at
room temperature. 300 μl of the upper aqueous phase was removed and mixed with 450 μl
99.9% ethanol (ratio 1:1.5), and processed in the RNeasy Mini Spin Columns (supplied in kit)
as specified by the manufacturer. An on-column DNase treatment was incorporated, using
RNase-Free DNase Set (Qiagen); 80 μl DNase solution was pipetted directly onto the column
membrane and incubated 15 min. Prior to elution, an additional centrifugation was performed
at 12,000xg for 2 min to prevent any carryover of buffers to the elution. RNA was eluted in
50 μl RNase-free water by centrifugation at 8,000xg for 2 min.
RNA purity and concentration was determined using a NanoDrop ND-1000 UV spectro-
photometer (Thermo Scientific); mean A260/280 ratio for all RNA samples was 2.1 and mean
A260/230 ratio was 2.0, RNA yields ranged from 396 to 1158 ng/μl, mean yield was 753.1 ng/μl.
RNA quality was estimated by measuring RNA integrity numbers (RIN) for each extraction,
using Agilent RNA 6000 Nano Chips and Agilent RNA 6000 Nano reagents on an Agilent 2100
Bioanalyzer (Agilent Technologies); RIN varied from 5.4 to 8.7, with the mean RIN value being
6.4. The same RNA extractions were applied in both RNAseq and RT-qPCR.
Small RNA sequencing
All procedures related to library preparation, sequencing, and quality control was carried out
by the sequencing provider Exiqon A/S (Vedbaek, Denmark). The RNA was diluted to 250 ng/
μl in RNase-free water and a total of 8 μl (2 μg RNA) from each sample was supplied to Exiqon
A/S for analysis. For each RNA sample, 1 μg of total RNA was converted into miRNA NGS
libraries using the NEBNext Small RNA Library Prep Set for Illumina (New England BioLabs)
according to the manufacturer’s instructions. Each individual RNA sample was converted into
cDNA and pre-amplified by PCR (protocol and reagents supplied with NEBNext kit). The 3’
PCR primer was associated with a barcode sequence that was unique for each original RNA
sample, thus allowing for differentiation of reads from different samples in the subsequent
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multiplex sequencing procedure of pooled cDNA samples. Libraries were purified using the
QIAquick PCR Purification Kit (Qiagen), and the insert efficiency evaluated on a Bioanalyzer
2100 instrument on high sensitivity DNA chips (Agilent Technologies) to confirm a peak at
~140 nt corresponding to the length of adapter-ligated miRNAs. The miRNA cDNA libraries
were size fractionated on a LabChip XT (Caliper Inc.) and a band representing adaptors and
15–40 nt insert (i.e. the size range covering miRNAs) excised according to the manufacturer’s
instructions. Samples were sequenced on the Illumina NextSeq 500 system, yielding 50 nt sin-
gle-ended reads of high quality (Q-score above 30). Raw sequencing data were supplied to the
authors as compressed FASTQ files.
Small RNA sequencing data analysis. RNAseq data analysis is summarized in Fig 2.
Adaptor sequences from the library preparation and sequencing were trimmed from the reads
Fig 2. Overview of RNAseq data analysis. Workflow of the bioinformatics tools applied for RNAseq data analysis.
https://doi.org/10.1371/journal.pone.0194765.g002
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using Cutadapt v. 1.8 [37], retaining only reads with a minimum length of 16 nt. Modules
from the miRDeep2 package v. 2.0.0.5 was applied for the remaining sequencing data process-
ing [38], using the mapper module to collapse trimmed reads and Bowtie v. 1.0.0 [39] for the
mapping of reads to a pre-built indexed porcine genome from the iGenomes collection from
Illumina (‘susScr3’ from UCSC built on the Sscrofa10.2 genome assembly [40], downloaded
January 27th 2015 from here: https://support.illumina.com/sequencing/sequencing_software/
igenome.html). The miRDeep2 module was supplied with .fa files with trimmed collapsed
sequencing reads and the indexed porcine genome (see above), .arf file with reads mapped to
the genome, and .fa files with known porcine miRNA sequences and known Homo sapiens,
Bos taurus, and Mus musculus miRNA sequences, respectively. The latter was applied for the
identification of potential novel (not yet annotated) porcine miRNAs candidates by comparing
the obtained read sequences to known mature miRNAs from other species. All miRNA
sequences were acquired from miRBase v. 21 [41].
Read counts were obtained from the miRDeep2 output file (.csv), and the remaining analy-
sis for differential expression and statistical analysis was performed in R (v. 3.4.2) [42] using
the package edgeR (v. 3.20.1) [43] and applying the general linearized model (glm) approach,
testing for significant differential expression between groups using an F-test. The Benjamini-
Hochberg procedure was applied to control the false discovery rate (FDR) at α = 0.05. miRNA
regulation was calculated as log2(fold change) (log2FC) of expression levels in a post-challenge
group relative to the control group. A miRNA was considered to be differentially expressed if
it was50% up- or down-regulated, i.e. log2FC > 0.585 or log2FC < -0.585, and significant in
an F-test (p< 0.05).
miRNA RT-qPCR
100 ng total RNA obtained from IAV infected porcine lung samples were reverse transcribed
into cDNA and pre-amplified prior to high-throughput qPCR using the method described by
Balcells, Cirera, and Busk [44], thus carrying out polyadenylation and reverse transcription in
the same reaction.–RT (reverse transcriptase replaced with water) and–poly(A) (poly(A) poly-
merase replaced with water) controls were included. Two cDNA replicates were synthesized
from each RNA sample. Residual primers were digested by Exonuclease I (New England Bio-
Labs) treatment. All miRNA primers, including the universal RT primer, were designed as
described previously [44] and purchased from Sigma-Aldrich. Whenever a porcine version of
a miRNA was and available in miRBase at the time of primer design, this sequence was used
(indicated by the prefix ssc). Otherwise, the sequence of the human (hsa) (or mouse, mmu, in
the case of novel miRNAs from sequencing data) homolog was used instead. Sequences and
qPCR efficiencies for all primers can be found in S1 Table. The majority of miRNAs assayed
by RT-qPCR were chosen based on RNAseq results. Additional miRNAs not detected by
sequencing were also included in the qPCR analysis, based on our previous work and literature
studies. qPCR was carried out in 96.96 Dynamic Array IFC chips using the high-throughput
BioMark HD real-time platform (Fluidigm). 96 sample mixes (including a non-template con-
trol, using water instead of cDNA) and 96 primer mixes were added to the 96.96 Dynamic
Array IFC chip, and a total of 9,216 qPCR reactions were carried out in parallel. Dilution series
were prepared from a pool of all samples (except –RT and –poly(A) controls) and included in
the qPCR to assess primer efficiency. Melting curve analysis was performed lastly to assess
qPCR specificity.
miRNA qPCR data analysis. All amplification and melting curves were visually inspected
using the Fluidigm Real-Time PCR Analysis software (v. 4.1.3). Primer efficiency was assessed
for each assay from the standard curves produced from the included dilution series and
IFN-λ and miRNAs as modulators of the pulmonary host response against influenza infection in pigs
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subsequently used to adjust the Cq values in the individual assays. Primer efficiencies ranged
from 92 to 119%. miRNA qPCR data was normalized using the global mean expression
method [45] and cDNA replicates were averaged. Cq values were converted to relative quanti-
ties on the linear scale. miRNA regulation was calculated as log2FC of expression levels in a
post-challenge group relative to the control group. A miRNA was considered to be differen-
tially expressed if it was50% up- or down-regulated, i.e. log2FC > 0.585 or log2FC < -0.585,
and significant in a t-test (p< 0.05, log2 transformed data), using the T.TEST() function in
Microsoft Excel (two-tailed, equal variance).
RT-qPCR of protein coding genes
For mRNA, the cDNA synthesis was performed with 500 ng RNA using the QuantiTect
Reverse Transcription Kit (Qiagen), including DNase treatment with gDNA Wipeout Buffer
(Qiagen).–RT controls (reverse transcriptase replaced with water) were included. Two cDNA
replicates were synthesized from each RNA sample. All cDNA samples were pre-amplified
prior to qPCR using TaqMan PreAmp Master Mix (Applied Biosystems) and a pool of all
primers to be included in the subsequent qPCR (at 200 nM each). Highly specific mRNA
primers were designed according to specification previously described [46] using Primer3
(http://bioinfo.ut.ee/primer3-0.4.0/). Included in the panel of assayed genes were a number of
potential reference genes (‘housekeeping genes’) that would later be evaluated for their suit-
ability for data normalization. Dilution series were prepared from a pool of all samples and
included in the qPCR (except the –RT control) to assess primer efficiency. Sequences and
qPCR efficiencies for all primers can be found in S1 Table. High-throughput qPCR was carried
out on the BioMark HD real-time instrument (Fluidigm) in a setup identical to that described
for miRNA (section ‘miRNA RT-qPCR’).
mRNA qPCR data analysis. All amplification and melting curves were visually inspected
using the Fluidigm Real-Time PCR Analysis software (v. 4.1.3). Primer efficiency was assessed
from the standard curves used to adjust the Cq values in the individual assays. Primer efficien-
cies ranged from 95 to 113%. Potential reference genes were evaluated using the algorithms
geNorm [47] and NormFinder [48], and β-actin (ACTB), β2 microglobulin (B2M), glyceralde-
hyde 3-phosphate dehydrogenase (GAPDH), peptidylprolyl isomerase A (PPIA), 60S ribo-
somal protein L13A (RPL13A), and tyrosine 3-monooxygenase/tryptophan 5-monooxygenase
activation protein, zeta polypeptide (YWHAZ) were applied for mRNA qPCR data normaliza-
tion. cDNA replicates were averaged and Cq values were converted to relative quantities on the
linear scale. mRNA regulation was calculated as log2FC of expression levels in a post-challenge
group relative to the control group. A protein coding gene was considered to be differentially
expressed if it was100% up- or down-regulated, i.e. log2FC> 1 or log2FC < -1, and signifi-
cant in a t-test (p< 0.05, log2 transformed data), using the T.TEST() function in Microsoft
Excel (two-tailed, equal variance).
miRNA-mRNA interactions
Using online tools and databases (see below), potential mRNA targets among the assayed pro-
tein coding genes were identified for miRNAs found to be differentially expressed after IAV
challenge. As very little experimental target validation has been performed for porcine miR-
NAs, the human miRNA homologs as well as protein coding genes were applied for target
identification and prediction. A comparison of porcine and human miRNA sequences applied
in miRNA-mRNA interaction analysis can be found in S2 Table, where the seed sequences
(nucleotides 2–7) have been highlighted, as these nucleotides are primarily responsible for
miRNA targeting specificity. One differentially expressed miRNA was excluded from these
IFN-λ and miRNAs as modulators of the pulmonary host response against influenza infection in pigs
PLOS ONE | https://doi.org/10.1371/journal.pone.0194765 April 20, 2018 7 / 23
analyses, as no human homolog has yet been annotated (ssc-miR-7134-5p, first identified in a
previous study of ours [49]). Previously experimentally validated and computationally pre-
dicted targets were identified by using each miRNA as input in a ‘single name’ search in the
RAIN database v. 1.0 [50], which integrates non-coding RNA interactions and associations
with the protein-protein interaction database STRING v. 10.5 [51]. As RAIN due to licensing
restrictions does not integrate information from TarBase v. 7.0 [52] or target predictions by
microT-CDS v. 5.0 [53] from DIANA Lab, previously experimentally validated and computa-
tionally predicted targets were likewise identified from these two sources. For all validated or
predicted miRNA-mRNA interactions obtained from RAIN, TarBase, and microT-CDS, Pear-
son’s correlation coefficient (Pearson’s r) was calculated for miRNA and mRNA expression
data (qPCR) on day 1 and 3 post challenge. If a negative correlation of r< -0.532 (p< 0.05)
was seen, that particular miRNA-mRNA interaction was regarded as potentially relevant in
the regulation of innate immune response in pigs during active IAV infection.
The RAIN database v. 1.0 [50] was likewise applied to identify cellular pathways that could
potentially be affected by the differentially expressed miRNAs. Two subsets of differentially
expressed miRNAs were applied as input in ‘multiple names’ search in RAIN: 1) miRNAs up-
regulated during acute infection on day 1 and/or 3 after challenge and 2) miRNAs down-regu-
lated during acute infection on day 1 and/or 3 after challenge. KEGG Pathway enrichment
analysis [54] (integrated in STRING) was performed on the collection of targets identified for
each set of the differentially expressed miRNAs.
Results
Animals and challenge
Clinical signs of IAV infection were observed in infected animals during the three first days
following challenge. Fever peaked on day 1 after challenge with a mean temperature of 41˚C,
which dropped to 39.9˚C on day 3. Dyspnea was likewise most severe on day 1 with a mean
score of 2.4, decreasing to 0.8 on day 3. No clinical signs were observed in control animals. As
reported previously [8], the challenge strain could be detected by qPCR in lung tissue on day 1
and 3 after challenge and in nasal swabs on day 1, 3, 5, and 7 after challenge. No IAV could be
detected on day 14 in nasal swabs or lung tissue [8].
Small RNA sequencing
Length distribution of reads (after adapter trimming) showed an expected peak around 18–23
nt, corresponding to typical miRNA length. The total number of reads obtained after sequenc-
ing ranged from 10.5 to 26.2 million per sample, averaging on 19.5 million. Of these, an aver-
age of 14.9 million reads mapped to the porcine genome, with an average of 7.5 million reads
mapping to known miRNAs (details for each sample provided in S3 Table). A total of 238
mature annotated porcine miRNAs could be detected in all of the samples (see S4 Table).
61 novel mature miRNA candidate sequences were obtained from the miRDeep2 pipeline
and subjected to BLASTN search in the miRBase database (v. 21) [41] to identify miRNA
homologs in other species. The best matching human homolog was chosen (highest score, low-
est E-value), unless a homolog from another species was a better match than the human homo-
log (higher score, lower E-value). Of the 61 candidate sequences, human homologs were
identified for 12, mouse homologs for two, and a bovine homolog for one sequence, respec-
tively (Table 1). More details (including candidate hairpin sequences and scores and E-values
from BLASTN) can be found in S5 Table. These 15 miRNA homologs were subsequently
included in qPCR analyses.
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Fold changes of miRNA expression (known and novel candidates) in lung tissue of infected
animals relative to the uninfected control animals were calculated. These results are shown in
volcano plots in Fig 3, highlighting the number of differentially expressed miRNAs at each of
the post-challenge time points, i.e. statistically significant up- or down-regulation. Log2FC of
all detected miRNAs are summarized in S6 Table. A total of 49 miRNAs were found to be dif-
ferentially expressed at one or more time points (p< 0.05) (Fig 4).
Comparison of RNAseq and qPCR results
qPCR expression data was obtained for a total of 80 miRNA (see S7 Table); 27 of these met the
criteria for being differentially expressed (log2FC > 0.585 or log2FC < -0.585, p< 0.05 (t-test))
(Table 2). Generally, good agreement was found between RNAseq and qPCR results. For those
miRNAs found to be differentially expressed at one or more time points after challenge by at
least one of the methods, a significant positive sample-wise correlation (Pearson’s r, p< 0.05)
of normalized RNAseq and qPCR expression values was seen for 74% of the miRNAs. Expres-
sion patterns for miRNAs found to be differentially expressed at one or more time points after
challenge obtained with the two methods are compared in Fig 5. Linear regression showed an
R2 of 0.6104, and a highly significant positive correlation (Pearson’s r) (r = 0.78, p< 0.01).
Table 1. Predicted novel porcine miRNA candidates and their known miRNA homologs.
Novel porcine miRNA
candidate
Novel porcine miRNA candidate sequence identified in
RNAseq data
Homolog
miRNA
Homolog accession
number
Homolog miRNA sequence
ssc-miR-novel-1 uucaaguaauucaggauagguu bta-miR-26b MIMAT0003531 uucaaguaauucaggauagguu
ssc-miR-novel-2 aaucacuaauuccacugccauc mmu-miR-
34b-3p
MIMAT0000382 aaucacuaacuccacugccauc
ssc-miR-novel-3 aggcaguguaauuagcugauugu mmu-miR-
34b-5p
MIMAT0004581 aggcaguguaauuagcugauug
ssc-miR-novel-4 uaacacugucugguaaagaug hsa-miR-141-
3p
MIMAT0000432 uaacacugucugguaaagaugg
ssc-miR-novel-5 caucuuccagcacaguguugga hsa-miR-141-
5p
MIMAT0004598 caucuuccaguacaguguugga
ssc-miR-novel-6 caucccuugcaugguggaggg hsa-miR-188-
5p
MIMAT0000457 caucccuugcaugguggaggg
ssc-miR-novel-7 uaauacugccugguaaugauga hsa-miR-200b-
3p
MIMAT0000318 uaauacugccugguaaugauga
ssc-miR-novel-8 caucuuacugggcagcauugga hsa-miR-200b-
5p
MIMAT0004571 caucuuacugggcagcauugga
ssc-miR-novel-9 uaauacugccggguaaugaugga hsa-miR-200c-
3p
MIMAT0000617 uaauacugccggguaaugaugga
ssc-miR-novel-10 uuuguucguucggcucgcguga hsa-miR-375 MIMAT0000728 uuuguucguucggcucgcguga
ssc-miR-novel-11 uggcaguguauuguuagcuggu hsa-miR-449a MIMAT0001541 uggcaguguauuguuagcuggu
ssc-miR-novel-12 aggcaguguauuguuagcuggc hsa-miR-449b-
5p
MIMAT0003327 aggcaguguauuguuagcuggc
ssc-miR-novel-13 uagugcaauauugcuuauagggu hsa-miR-454-
3p
MIMAT0003885 uagugcaauauugcuuauagggu
ssc-miR-novel-14 uaauuuuauguauaagcuagu hsa-miR-590-
3p
MIMAT0004801 uaauuuuauguauaagcuagu
ssc-miR-novel-15 uacccauugcauaucggaguug hsa-miR-660-
5p
MIMAT0003338 uacccauugcauaucggaguug
When equally identical homologs were found in several species, the human homolog is shown here. Species specific prefixes are as follows: ssc—Sus scrofa, hsa—Homo
sapiens, bta—Bos taurus, and mmu—Mus musculus.
 indicates that the novel porcine sequence is not 100% identical to its matching homolog (see underlined bold nucleotides).
https://doi.org/10.1371/journal.pone.0194765.t001
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Fig 3. Volcano plots showing miRNA expression changes as obtained by RNAseq. A) day 1 after challenge, B) day 3 after challenge, C) day 14 after challenge. x-axes
show the log2FC values of post-challenge time points vs. unchallenged controls. 50% up- or down-regulation is denoted by vertical dotted lines (log2FC> 0.585, log2FC<
-0.585). y-axes show the -log10 transformed p-values obtained from F-tests. p = 0.05 is denoted by a horizontal red line. A horizontal blue line denotes the p-value limit for
significant differential expression when controlling for FDR; as shown, only on day 3 after challenge are there any miRNAs that are significantly differentially expressed
after this correction. miRNAs that pass the criteria for differential expression are marked with a number denoting their identity; miRNAs that appear in more than one
volcano plot are marked with the same number in all plots. 1 ssc-miR-205; 2 ssc-miR-34c; 3 ssc-miR-671-5p; 4 ssc-miR-146a-5p; 5 ssc-miR-2366; 6 ssc-miR-365-5p; 7 ssc-
miR-146b; 8 ssc-miR-708-5p; 9 ssc-miR-92b-5p; 10 ssc-miR-708-3p; 11 mmu-miR-34b-3p; 12 mmu-miR-34b-5p; 13 ssc-miR-339-3p; 14 ssc-miR-196b-5p; 15 ssc-miR-
193a-3p; 16 ssc-miR-4334-3p; 17 ssc-miR-133b; 18 ssc-miR-217; 19 ssc-miR-331-3p; 20 ssc-miR-216; 21 ssc-miR-187; 22 ssc-miR-144; 23 ssc-miR-296-3p; 24 ssc-miR-
92b-3p; 25 ssc-miR-1343; 26 hsa-miR-375; 27 ssc-miR-744; 28 ssc-miR-7134-5p; 29 ssc-miR-190b; 30 ssc-miR-2320-3p; 31 ssc-miR-671-3p; 32 ssc-miR-128; 33 ssc-miR-
328; 34 ssc-miR-30c-1-3p; 35 ssc-miR-1296-5p; 36 ssc-miR-149; 37 ssc-miR-183; 38 ssc-miR-129b; 39 ssc-miR-221-5p; 40 ssc-miR-29b; 41 ssc-miR-142-5p; 42 ssc-miR-
504; 43 ssc-miR-20a; 44 ssc-miR-1249; 45 ssc-miR-7139-3p; 46 ssc-miR-486; 47 ssc-miR-451; 48 ssc-miR-335; 49 ssc-miR-215.
https://doi.org/10.1371/journal.pone.0194765.g003
Fig 4. Venn diagram comparing differentially expressed miRNAs identified by and qPCR and RNAseq. Overlap of
miRNAs found to be differentially expressed at one or more post-challenge time points by RNAseq (yellow) and qPCR
(blue). †miRNAs assayed by qPCR but not detected by sequencing; miRNAs detected by sequencing, but not assayed
by qPCR. When a known porcine (ssc) sequence for a given miRNA was not available in miRBase (v. 21), human (hsa)
or mouse (mmu) names are applied in accordance with the homolog that best matched the novel porcine miRNA
discovered in the RNAseq data, and these homolog sequences were likewise used for qPCR primer design.
https://doi.org/10.1371/journal.pone.0194765.g004
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Results from both methods concur that day 3 is the time point where there is the highest
number of differentially expressed miRNAs (Table 2). qPCR analysis on day 3 showed 19 miR-
NAs to be differentially expressed relative to the control group; only roughly half as many were
differentially expressed on day 1 and 14. Only two miRNAs were significantly changed
throughout the whole experiment: ssc-miR-34c and ssc-miR-92b-3p. Both were down-regu-
lated at very similar levels at all post-challenge time points.
qPCR of protein coding genes
Analysis of differential expression of protein coding genes was focused primarily on factors of
the antiviral innate immune system and apoptosis, thus gathering a thorough characterization
of the processes that are engaged to combat the IAV infection locally in the lung of our pig
model. A total of 49 genes were identified by RT-qPCR as being differentially expressed
Table 2. Differential expression of miRNAs measured by qPCR in pig lungs after IAV challenge relative to unchallenged controls.
Day 1 after challenge relative to control group Day 3 after challenge relative to control group Day 14 after challenge relative to control
group
miRNA log2FC (lower 95% CI; upper 95%
CI)
p (t-test) log2FC (lower 95% CI; upper 95%
CI)
p (t-test) log2FC (lower 95% CI; upper 95%
CI)
p (t-test)
ssc-miR-7 1.2 (0.79; 1.5) 0.0019 0.70 (0.15; 1.1) 0.065 -0.43 (-0.67; -0.22) 0.13
ssc-miR-15a† 0.41 (0.25; 0.56) 0.0070 0.63 (0.53; 0.73) 8.9E-05 0.23 (0.049; 0.39) 0.10
ssc-miR-18a 0.12 (-0.16; 0.37) 0.57 0.65 (0.45; 0.81) 0.0033 0.36 (0.18; 0.53) 0.043
ssc-miR-21 -0.12 (-0.39; 0.11) 0.50 0.75 (0.65; 0.84) 0.00016 0.27 (0.085; 0.44) 0.096
ssc-miR-29b 0.37 (0.17; 0.54) 0.020 0.58 (0.38; 0.76) 0.0014 -0.12 (-0.30; 0.038) 0.28
mmu-miR-34b-
3p
-0.76 (-1.5; -0.28) 0.058 -1.0 (-1.3; -0.85) 0.0019 -0.56 (-0.93; -0.26) 0.079
ssc-miR-34c -1.0 (-1.5; -0.67) 0.0026 -2.2 (-3.3; -1.6) 0.00026 -0.95 (-1.3; -0.66) 0.0029
ssc-miR-92b-3p -0.85 (-1.2; -0.57) 0.0045 -2.2 (-2.6; -1.9) 3.4E-06 -1.2 (-1.4; -0.98) 9.4E-05
ssc-miR-146a-5p -0.58 (-0.91; -0.30) 0.034 -0.43 (-0.86; -0.098) 0.10 -0.087 (-0.35; 0.13) 0.65
ssc-miR-184 -0.60 (-1.9; 0.072) 0.27 -1.1 (-1.5; -0.78) 0.047 -0.25 (-0.70; 0.094) 0.74
ssc-miR-193a-3p 0.58 (0.36; 0.78) 0.0028 0.73 (0.43; 0.97) 0.0017 0.16 (-0.10; 0.38) 0.46
ssc-miR-205 -1.1 (-1.8; -0.64) 0.028 -2.2 (-2.7; -1.8) 0.00021 0.088 (-0.41; 0.46) 0.84
ssc-miR-221-5p 1.1 (0.56; 1.5) 0.0066 1.1 (0.15; 1.7) 0.040 -0.31 (-1.2; 0.22) 0.27
hsa-miR-223-5p† 0.57 (0.32; 0.79) 0.023 1.1 (0.86; 1.4) 0.00042 0.17 (-0.068; 0.37) 0.40
ssc-miR-296-3p -0.12 (-0.38; 0.10) 0.58 -0.67 (-0.96; -0.43) 0.016 -0.57 (-0.82; -0.36) 0.015
ssc-miR-363 0.20 (-0.057; 0.42) 0.40 0.69 (0.44; 0.90) 0.011 -0.10 (-0.33; 0.095) 0.76
hsa-miR-375 -0.82 (-1.1; -0.61) 0.00031 -0.78 (-1.2; -0.43) 0.0053 -0.11 (-0.26; 0.023) 0.30
ssc-miR-378 -0.28 (-0.40; -0.17) 0.18 -0.42 (-0.47; -0.38) 0.042 -0.62 (-0.91; -0.37) 0.018
hsa-miR-449a -0.28 (-0.78; 0.086) 0.25 -0.50 (-1.1; -0.059) 0.10 0.77 (0.47; 1.0) 0.0060
hsa-miR-449b-5p -0.38 (-0.90; 0.0040) 0.18 -0.59 (-1.2; -0.16) 0.076 0.73 (0.48; 0.95) 0.0058
ssc-miR-451 0.84 (-0.71; 1.6) 0.20 1.4 (-1.2; 2.3) 0.080 1.4 (0.37; 2.0) 0.045
ssc-miR-551a -0.15 (-0.40; 0.059) 0.35 -0.82 (-1.1; -0.57) 0.0035 -1.0 (-1.3; -0.75) 0.00022
hsa-miR-590-3p† 0.36 (0.049; 0.61) 0.14 0.74 (0.23; 1.1) 0.027 -0.026 (-0.35; 0.24) 0.86
ssc-miR-671-3p -0.43 (-0.69; -0.21) 0.021 -0.36 (-0.66; -0.11) 0.057 -0.58 (-0.69; -0.48) 6.7E-05
ssc-miR-708-5p -0.74 (-0.90: -0.60) 0.0022 -0.43 (-0.88; -0.080) 0.14 -0.67 (-1.0; -0.41) 0.014
ssc-miR-1343 -0.40 (-0.69; -0.15) 0.073 -0.91 (-1.2; -0.66) 0.0016 -0.21 (-0.38; -0.058) 0.23
ssc-miR-7134-5p -0.46 (-0.82; -0.17) 0.040 -0.98 (-1.2; -0.79) 0.00013 -0.73 (-0.91; -0.57) 0.00035
Log2FC of miRNA expression on day 1, 3, and 14 after IAV challenge relative to unchallenged controls. Lower and upper limits for 95% confidence interval are given in
parentheses. Data in bold text are those that meet the criteria for differential expression (see text). p-values were obtained from t-test between the control group and a
post-challenge group. †miRNAs that were not identified in RNAseq data.
https://doi.org/10.1371/journal.pone.0194765.t002
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(log2FC > 1 or log2FC < -1, p< 0.05 (t-test)) in the lung at one or more time points after
infection (Table 3, full list in S8 Table).
A dramatic interferon response dominated on day 1 after challenge, demonstrated by a
log2FC of 8.7 and 6.3 for IL28B (IFN-λ3) and IFNB1 (IFN-β), respectively (Table 3). The most
strongly up-regulated PRRs were the two cytoplasmic RLRs RIG-I (DDX58) and MDA5
(IFIH1) (log2FC 6.1 and 3.5 on day 1 after challenge, respectively) (S8 Table). Other up-regu-
lated PRRs included TLRs 3 and 7 (log2FC 2.5 and 1.8 on day 1 after challenge, respectively)
(S8 Table). These four PRRs all remained significantly up-regulated on day 3 after challenge.
Several cytokines with both pro- and anti-inflammatory functions were also up-regulated on
day 1 and (partly) day 3 after challenge, including IL1B (IL-1β), IL6 (IL-6), IL1RN (IL-1RA),
and IL10 (IL-10) (S8 Table). The only cytokine to demonstrate down-regulation in response to
IAV infection was the pro-inflammatory IL18 (IL-18). A strong chemokine response, espe-
cially by CCL2 (CCL2) and CXCL10 (CXCL10), was also detected on day 1 after challenge (S8
Table). Additionally, the importance of apoptosis in the response to IAV infection was clearly
demonstrated by the early up-regulation of e.g. genes related to the Jak/STAT signaling path-
way (STAT1, STAT2, JAK2, IRF2, IRF7, SOCS1), as well as caspases 1 and 3 (CASP1, CASP3),
Bcl-2 (BLC2), Mcl-1 (MCL1), and protein kinase R (EIF2AK2) (Table 3).
Only one of the assayed protein coding genes was regulated on day 14 after challenge: the
positive acute-phase protein (APP) serum amyloid A (SAA) showed a log2FC of -2.6 at this
time point (Table 3). SAA was not differentially expressed at earlier time points; however,
transferrin (TF) and PAI-1 (SERPINE1) were regulated on day 3 after challenge in accordance
with their roles as negative and positive APPs (log2FC -1.4 and 2.2, respectively) (Table 3).
Target identification of differentially expressed miRNAs
Previously experimentally validated or computationally predicted targets (obtained with
RAIN, TarBase, and microT-CDS) for the differentially expressed miRNAs among the protein
coding genes assayed in the present study was identified using the RAIN database [50], Tar-
Base v. 7.0 [52], and microT-CDS v. 5.0 [53]. For a number of these miRNA-mRNA interac-
tions, a significant negative correlation (r< - 0.532, p< 0.05) was seen for the expression
during active viral infection on day 1 and 3 post challenge. These interactions are summarized
Fig 5. Comparison of miRNA log2FC as measured by RNAseq and qPCR. Log2FC (challenged group vs. control
group) obtained by qPCR is plotted against the corresponding log2FC obtained by RNAseq. Each point represents
log2FC of one miRNA on day 1 (black), day 3 (white), or day 14 (grey) after challenge.
https://doi.org/10.1371/journal.pone.0194765.g005
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in Fig 6. Potential functional implications of miRNA regulation was assessed by KEGG Path-
way enrichment analysis of genes identified with RAIN to be validated or predicted targets of
the subsets of miRNAs found to be up- or down-regulated during acute infection on day 1 and
3 after challenge. Substantial overlap of enriched pathways was seen for those two sets of target
Table 3. Differential expression of protein coding genes in pig lungs after IAV infection relative to unchallenged controls.
Day 1 after challenge relative to
control group
Day 3 after challenge relative to
control group
Day 14 after challenge relative to
control group
Gene product Gene log2(FC) (lower 95% CI;
upper 95% CI)
p (t-test) log2(FC) (lower 95% CI;
upper 95% CI)
p (t-test) log2(FC) (lower 95% CI;
upper 95% CI)
p (t-test)
Interferon and interferon stimulated genes
IFN-λ3 (interferon-λ3) IL28B 8.7 (7.8; 9.2) 2.2E-08 6.1 (3.3; 7.0) 0.0014 1.2 (0.33; 1.7) 0.098
IFN-β (interferon-β) IFNB1 6.3 (5.3; 6.9) 1.5E-06 4.6 (3.2; 5.3) 0.00057 0.71 (-0.15; 1.2) 0.43
ISG15 (interferon-stimulated gene 15) ISG15 6.3 (5.9; 6.7) 6.3E-07 4.0 (2.6; 4.7) 0.012 1.1 (0.0; 2.6) 0.50
IFITM1 (interferon-induced
transmembrane protein 1)
IFITM1 3.6 (3.2; 3.9) 7.4E-07 2.0 (1.2; 2.5) 0.0057 0.25 (-2.7; 1.1) 0.74
IFITM3 (interferon-induced
transmembrane protein 3)
IFITM3 3.3 (2.7; 3.7) 0.000010 2.1 (1.3; 2.6) 0.0025 0.23 (0.0; 1.2) 0.59
IRF2 (interferon regulatory factor 2) IRF2 1.8 (1.4; 2.1) 0.000060 0.59 (0.013; 1.0) 0.086 -0.094 (-0.21; 0.012) 0.41
IRF7 (interferon regulatory factor 7) IRF7 4.7 (4.4; 5.0) 1.5E-07 3.0 (2.0; 3.6) 0.0064 0.22 (-5.0; 1.2) 0.63
SOCS1 (suppressor of cytokine
signalling 1)
SOCS1 3.0 (2.4; 3.4) 0.000027 1.8 (0.91; 2.3) 0.0063 -0.15 (-0.32; 0.013) 0.61
Mx1 (interferon-induced GTP-binding
protein Mx1)
MX1 5.5 (5.1; 5.8) 1.6E-07 3.4 (2.2; 4.1) 0.012 0.67 (0.0; 1.9) 0.54
OASL (59 kDa 2’-5’-oligoadenylate
synthetase-like protein)
OASL 5.3 (4.9; 5.5) 2.5E-07 4.3 (3.2; 4.9) 0.018 0.47 (0.0; 1.5) 0.73
OAS1 (2’-5’-oligoadenylate synthetase 1) OAS1 3.5 (3.2; 3.8) 3.8E-06 1.6 (0.90; 2.1) 0.022 -0.74 (-2.9; 0.091) 0.09
PKR (protein kinase R) EIF2AK2 3.3 (3.0; 3.6) 1.8E-06 1.9 (1.1; 2.4) 0.015 -0.16 (-1.3; 0.48) 0.52
RNase L (ribonuclease L) RNASEL 3.4 (3.0; 3.8) 9.6E-06 1.4 (0.23; 2.0) 0.074 -0.24 (-0.76; 0.14) 0.62
STAT1 (signal transducer and activator
of transcription 1)
STAT1 3.4 (3.0; 3.7) 1.7E-07 2.1 (1.3; 2.5) 0.00020 0.45 (0.10; 0.73) 0.15
STAT2 (signal transducer and activator
of transcription 2)
STAT2 2.7 (2.3; 3.0) 3.2E-06 0.94 (0.17; 1.4) 0.11 -0.28 (-0.92; 0.17) 0.20
JAK2 (Janus kinase 2) JAK2 2.0 (1.6; 2.3) 0.0000097 1.2 (0.92; 1.4) 0.000016 0.32 (0.13; 0.48) 0.047
Apoptosis
CASP1 (caspase-1) CASP1 1.7 (1.3; 2.1) 0.0025 0.69 (-0.075; 1.2) 0.26 -0.45 (-1.1; 0.0071) 0.39
CASP3 (caspase-3) CASP3 1.8 (1.4; 2.1) 0.00014 1.1 (0.90; 1.3) 0.000046 0.42 (0.059; 0.70) 0.18
Bcl-2 (B-cell lymphoma 2) BCL2 2.3 (1.8; 2.7) 0.000061 0.90 (0.45; 1.2) 0.012 0.31 (-0.19; 0.68) 0.45
Mcl-1 (induced myeloid leukemia cell
differentiation protein Mcl-1)
MCL1 1.5 (1.1; 1.9) 0.00015 0.69 (0.37; 0.95) 0.0032 0.25 (0.63; 0.41) 0.079
FasR (FAS receptor) FAS 2.1 (1.4; 2.5) 0.00028 0.93 (0.43; 1.3) 0.018 0.23 (-0.049; 0.47) 0.34
FasL (FAS ligand) FASLG 1.8 (1.5; 2.0) 0.00018 0.82 (0.10; 1.3) 0.062 -0.16 (-0.45; 0.085) 0.79
GZMB (granzyme B) GZMB 1.7 (1.5; 1.9) 0.00062 1.0 (0.64; 1.3) 0.017 -0.12 (-0.30; 0.043) 0.82
Acute phase proteins
SAA (serum amyloid A) SAA 0.90 (0.43; 1.3) 0.061 -0.12 (-1.0; 0.44) 0.80 -2.6 (-3.2; -2.1) 0.00011
PAI-1 (plasminogen activator inhibitor-
1)
SERPINE1 2.5 (1.9; 3.0) 0.000038 2.2 (0.70; 2.9) 0.0063 -0.016 (-0.80; 0.49) 0.60
TF (transferrin) TF -0.90 (-1.3; -0.59) 0.014 -1.4 (-2.3; -0.85) 0.013 -0.83 (-1.3; -0.45) 0.018
Log2FC of mRNA expression on day 1, 3, and 14 after IAV challenge relative to unchallenged controls. Lower and upper limits for 95% confidence interval are given in
parentheses. Data in bold text are those that meet the criteria for differential expression (see text). p-values were obtained from t-test between the control group and a
post-challenge group.
https://doi.org/10.1371/journal.pone.0194765.t003
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genes, including ‘Influenza A’ (ID 5164), ‘Apoptosis’ (ID 4210), ‘Jak-STAT signaling’ (ID
4630), ‘NF-κB signaling’ (ID 4064), ‘Cytokine-cytokine receptor interaction’ (ID 4060), ‘Che-
mokine signaling’ (ID 4062), and ‘Endocytosis’ (4144). Among the enriched pathways of rele-
vance to IAV infection, the following were found to be enriched only in one of sets of target
genes: ‘B cell receptor signaling’ (ID 4662), ‘Natural killer cell mediated cytotoxicity’ (ID
4650), and ‘Antigen processing and presentation’ (ID 4612) were enriched only in targets of
up-regulated miRNAs on day 1 and 3 after challenge, and ‘Toll-like receptor signaling’ (4620),
‘NOD-like receptor signaling’ (ID 4621), and ‘RIG-I-like receptor signaling’ (ID 4622) were
enriched only in targets of down-regulated miRNAs on day 1 and 3 after challenge. The
miRNA-target interaction networks that form the basis for the KEGG Pathway enrichment
analysis can be viewed in S1 and S2 Figs.
Discussion
Temporal dynamics of the antiviral response
Transcriptional analysis showed several known miRNAs and novel miRNA candidates to be
differentially expressed in the lungs of pigs experimentally infected with H1N2 swine IAV rela-
tive to lung tissue from healthy controls. Differentially expressed miRNAs were identified at all
examined post-challenge time points (day 1, 3, and 14 after challenge). To the best of our
knowledge, this is the first study to present global characterization of miRNA expression in pig
lungs after IAV infection. However, several of the miRNAs we found to be differentially
expressed have previously been reported to display similar regulation in mouse lung tissue
during acute infection after challenge with seasonal H1N1 [26,55] or pandemic (2009) H1N1
[56]. These include ssc-miR-7 [56], ssc-miR-15a [26], ssc-miR-18a [26,56], ssc-miR-21 [55,56],
mmu-miR-34b-3p [26], ssc-miR-34c [26], ssc-miR-92b-3p [26], ssc-miR-193a-3p [55], hsa-
miR-449a [26], and ssc-miR-671-3p [26]. Three of the up-regulated miRNAs (ssc-miR-7, ssc-
miR-221-5p, and ssc-miR-451) likewise overlapped with miRNAs we have previously found to
be up-regulated in necrotic lung tissue compared to visually unaffected lung tissue of pigs
experimentally infected with the Gram-negative bacterium Actinobacillus pleuropneumoniae
[49], suggesting a potential common function of these during both viral and Gram-negative
bacterial pulmonary infection in pigs.
Fig 6. Potential miRNA-mRNA interactions. Expression of eight of the assayed miRNAs showed significant negative
correlation with expression of protein coding genes that were identified (using RAIN v1.0 [50], TarBase v. 7.0 [52],
and/or microT-CDS [53]) to be experimentally validated targets of the miRNA (solid lines), computationally predicted
targets of the miRNA (dotted lines), or both (solid lines, underlined gene names).
https://doi.org/10.1371/journal.pone.0194765.g006
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The majority of differential miRNA expression was found to occur at day 3 after challenge;
this is in contrast to our previous findings of miRNA expression in circulating leukocytes of
the same animals, where the number of differentially expressed miRNAs peaked after viral
clearance, 14 days after challenge [57]. The role of miRNAs expressed in the lung may thus be
more focused on modulating transcripts related to the active viral infection. However, in both
infected lung tissue and circulating leukocytes the lowest number of differentially expressed
miRNAs was seen on day 1 after challenge, whereas the number of differentially expressed pro-
tein coding genes related to the antiviral immune response was at its highest at this time point.
The miRNA response in the porcine lung may thus be a secondary response with the aim of
containing and balancing the rapid inflammatory response upon IAV infection, which if left
unchecked may cause massive tissue damage [58].
In terms of clinical symptoms, IAV infection is a short-lived disease in otherwise healthy
individuals. However, we here demonstrated in a relevant porcine model that even on day 14
after challenge (when the virus had been cleared), remodeling of the miRNA expression of the
lung tissue persisted. Similar results of miRNA regulation in the lungs of mice at late time
points after IAV (H1N1) infection were recently published [59]. These authors demonstrated
significantly altered expression of miRNAs at 21 days after IAV challenge, including up-regu-
lation of miR-449a which is in agreement with our results 14 days after challenge in the pig
lung. Recuperation from IAV infection thus appears to be a protracted process involving miR-
NAs both locally at the infection site as well as systemically. Such lingering remodeling of the
miRNA landscape after viral infection may have important consequences for lung homeostasis
and susceptibility to secondary infections. Additional evidence of long term effects of IAV
infection locally in the pig lung is seen in the down-regulation of SAA 14 days after challenge.
This peculiar finding confirms results we have previously published [8]. This conventionally
positive APP showed no significant pulmonary regulation during the acute phase of the disease
in the lung of IAV infected pigs. However, several reports confirm elevated levels of SAA in
serum from pigs within 2–3 days after IAV (H1N1, H1N2, H3N2) infection [60–62]. Thus,
there appear to be a role for hepatically produced SAA during the acute phase of IAV infection
in pigs, rather than locally produced pulmonary SAA. SAA has been reported to have chemo-
tactic and pro-inflammatory effects [63]; down-regulation of SAA during recuperation may
thus be a means to restore lung homeostasis after IAV infection.
Pulmonary type III interferon in pigs
Despite the important role for type III interferon in IAV infection, the pulmonary IFN-λ
response remains uncharacterized in the pig. To the best of our knowledge, the present study
is the first to report the regulation of IFN-λ in pigs in response to IAV infection. Type III inter-
ferons (IFN-λ1, IFN-λ2, IFN-λ3, and IFN-λ4) are the most recently described members of the
interferon family [64]. Like their type I interferon (IFN-α and IFN-β) counterparts, they have
been shown to be crucial inducers of the antiviral response upon IAV infection in mice and in
vitro systems [5]. However, in contrast to the type I interferon receptor, which is expressed on
the surface of a wide variety of cells, the type III interferon receptor is considered to be largely
restricted to epithelial cell surfaces [64,65]. Lung-infiltrating neutrophils in mice have also
been demonstrated to respond to type III interferon [66]. Nevertheless, type III and type I
interferon signaling through their respective receptors do activate the same ISGs. Mouse
experiments have demonstrated IFN-λ to be important for restriction of viral replication and
to be the earliest type of interferons produced in response to IAV infection [66,67]. This antivi-
ral function is mediated via ISGs such as Mx1, PKR, and ISG15 [68], which were all found to
be up-regulated in the present study.
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Fang et al. showed that protein levels of IFN-λ1 were elevated in serum in an influenza
patient cohort compared to healthy controls. They furthermore demonstrated that hsa-miR-29
(especially hsa-miR-29b-3p) indirectly mediate IFNL1 up-regulation by controlling DNA
methyltransferase (DNMT3A and DNMT3B) activity in human pulmonary epithelial cells
(A549) and a subsequent IRF3/IRF7 dependent transcription of IFNL1 via COX2 (PTGS2), a
potent inflammatory protein in IAV infection [69]. Our results mirror these findings in
human patients and cells: IFN-λ (IL28B) was >400-fold up-regulated (log2FC 8.7) in the por-
cine lung 1 day after IAV challenge, and remained up-regulated on day 3. IRF7 was also highly
up-regulated at these time points. Finally, we also found ssc-miR-29b to be modestly up-regu-
lated on day 1 and 3 after challenge, suggesting that ssc-miR-29b mediated up-regulation of
IL28B via COX2 and IRF7 may also contribute to the antiviral response in IAV infection in
our pig model.
The prominent up-regulation of type III interferon gene expression compared to type I
interferon suggested that the antiviral interferon response may be somewhat tailored to epithe-
lial cells, as these are the cells that primarily express the type III interferon receptor. This sug-
gests a preferred targeting of cells that actually contain the virus, as respiratory epithelial cells
are the main site for IAV replication in vivo [10]. This tailored approach could contribute to
lowered tissue damage and disease severity than what might be expected from a dominating
type I interferon response as type I receptors are present on a wider range of cells. Corroborat-
ing results were recently published by Galani et al., who found that pulmonary type I inter-
feron mediated a stronger pro-inflammatory response and increased immunopathology
compared to type III interferons in H1N1 IAV infected mice [66]. Here, in our pig model
inducing relatively mild IAV disease, we accordingly found the type III interferon to be the
dominating response. It can be speculated that the severity of IAV infection relates to the bal-
ance between the type I and III interferon responses, with the more severe clinical and immu-
nopathological manifestations being associated with at higher type I interferon response.
miRNA modulation of the antiviral response
In addition to the abovementioned possible involvement of ssc-miR-29b in the IFN-λ3
response, our results likewise suggested miRNA-mediated modulation of other branches of
the innate response to IAV infection in the pig. A number of the assayed protein coding genes
were found to be targets (either previously experimentally validated or computationally pre-
dicted) of the miRNAs found to be differentially expressed after IAV infection in pigs. Our
results supported that some of these interactions are potentially important for the porcine pul-
monary response to IAV infection, given that the expression of eight of these miRNAs and
their target mRNAs was significantly and negatively correlated during active infection (day 1
and 3 after challenge only). Prominent among the miRNA targeted genes were antiviral PRRs
(IFIH1 and TLR3) and genes related to apoptosis (BCL2, MCL1, CASP1, CASP3, FASLG, and
EIF2AK2). It is well established that apoptosis occurs in the host during IAV infection, both as
a host response to limit viral replication and spread, but also directly induced by viral proteins
for the benefit of the virus [10,70,71]. Common to all five miRNAs found to correlate nega-
tively with apoptosis-related gene expression (ssc-miR-15a, ssc-miR-18a, ssc-miR-21, ssc-miR-
29b, and hsa-miR-590-3p) is that they were significantly up-regulated on day 3 after challenge,
and not regulated at other time points. This concurs with the expression of the apoptosis-
related genes, all down-regulated at day 3 compared to their initial up-regulation on day 1.
The same pattern holds true for the expression IFIH1 and TLR3 and the miRNAs that target
them (ssc-miR-29b, ssc-miR-18a, and hsa-miR-590-3p). This negative correlation between
miRNA expression and their target transcripts thus suggest the specific involvement of ssc-
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miR-15a, ssc-miR-18a, ssc-miR-21, ssc-miR-29b, and hsa-miR-590-3p in the modulation of
important signaling cascades of apoptosis and viral recognition. Given the likely suppressive
effect of these miRNAs on their target genes’ protein output, the miRNA-mediated down-reg-
ulation of IFIH1 and TLR3 may be way of limiting the pro-inflammatory effects of viral PRR
signaling upon IAV infection in order to limit immunopathology. Concordantly, the pro-
inflammatory factors IL1B and CXCL10 are likewise among the miRNA-targeted genes show-
ing significant negative correlation with one or more miRNAs and a strong up-regulation on
day 1 after challenge but not on day 3.
Gene targets for the differentially expressed miRNAs were identified using online databases
and prediction tools, and subjected to KEGG Pathway enrichment analysis. A large overlap of
enriched pathways relevant to IAV infection was seen for genes targeted by either up- or
down-regulated miRNAs on day 1 and 3 after challenge, including ‘Influenza A’, ‘Apoptosis’,
‘Endocytosis’, ‘Jak-STAT signaling’, ‘NF-κB signaling’, ‘Cytokine-cytokine receptor interac-
tion’, and ‘Chemokine signaling’. This coinciding up- and down-regulation of miRNAs that
target such central pathways activated during IAV infection exemplifies the role of miRNAs in
balancing and fine-tuning the antiviral innate immune response. Interestingly, we found the
pathways ‘Toll-like receptor signaling’, ‘NOD-like receptor signaling’, and ‘RIG-I-like receptor
signaling’ to be enriched only in targets of miRNAs down-regulated on day 1 and 3 after chal-
lenged. Based on KEGG Pathway enrichment analysis, viral recognition thus appears to be one
general aspect of the antiviral response that is not subject miRNA fine-tuning during active
IAV infection.
qPCR validation of RNAseq results
In the present study RNAseq miRNA expression results were validated using high-throughput
qPCR. Generally, we found the agreement between RNAseq and qPCR results to be good with
respect to directionality of miRNA regulation (up, down, or unchanged). These expression
patterns were largely identical in both datasets with only two noticeable exceptions: ssc-miR-
339-3p, which was significantly up-regulated in RNAseq but unchanged in qPCR, and mmu-
miR-34b-5p, which was significantly down-regulated in RNAseq but also unchanged in qPCR.
This lack of agreement could be caused by factors inherent to either method, e.g. poorly
designed qPCR primers or the presence of isomiRs which would be detected by RNAseq but
not qPCR and would thus contribute to expression levels in one dataset but not the other [72].
However, although there is a general agreement on the regulation patterns of the miRNAs
between the two platforms, levels of regulation (i.e. fold change of expression) and statistical
significance did not always concur. The relatively small changes that are typically observed
when measuring differential miRNA expression combined with considerable animal-to-ani-
mal variation and difference in platform sensitivity makes it challenging to produce consistent
statistically significant results.
To our knowledge, few studies of large-scale qPCR validation of RNAseq miRNA expres-
sion results have yet been published. One such study by Blondal et al. described the quantifica-
tion of miRNAs in serum of hepatitis B and C patients [73], and reported a linear correlation
(R2) of 0.6054 between fold changes obtained with the two platforms, which is highly compara-
ble to our own findings (R2 = 0.6104). Also consistent with our observations is the fact that
Blondal et al. found the levels of fold change to differ between the two platforms for many of
the assayed miRNAs, even though the directionality of regulation was in agreement. Another
study of miRNA quantification in the urine of rats with renal tubular injury reported minimal
agreement between RNAseq and qPCR results [74]. The authors detected 14 differentially
expressed miRNAs with RNAseq and 32 with RT-qPCR; of these, an overlap of only three
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miRNAs that were supported by both platforms. Our findings as well as the available literature
thus suggest that extensive validation of results obtained with RNAseq should be performed
with an independent platform, in order to produce consistent and reliable miRNA expression
results.
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